Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Labetalol for Controlled Hypotension in DCR Surgery
NCT06346561Recruiting
- Sponsor
- Sohag University
- Start
- Mar 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in nasolacrimal duct obstruction (NLDO) (2 arms), sponsored by Sohag University. Primary endpoint: Non-invasive Blood Pressure. Started Mar 2024; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
nasolacrimal duct obstruction (NLDO)
Beyond the preview
Go deeper on NCT06346561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06346561.